135 related articles for article (PubMed ID: 37326385)
1. Construction of refined staging classification systems integrating FIGO/T-categories and corpus uterine invasion for non-metastatic cervical cancer.
Huang XD; Chen K; Shi L; Luo YS; Ou-Yang Y; Li JY; Huo LQ; Huang L; Chen FP; Cao XP
Cancer Med; 2023 Jul; 12(14):15079-15089. PubMed ID: 37326385
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer.
Huang XD; Huo LQ; Luo YS; Chen K; Li JY; Shi L; Huang L; Cao XP; Ou-Yang Y; Chen FP
Ther Adv Med Oncol; 2023; 15():17588359231165974. PubMed ID: 37025259
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma.
Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ
JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
[TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
[TBL] [Abstract][Full Text] [Related]
7. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a new staging system for node-negative gastric cancer based on recursive partitioning analysis: An international multi-institutional study.
Lin JX; Wang ZK; Wang W; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Zhou ZW; Huang CM
Cancer Med; 2019 Jun; 8(6):2962-2970. PubMed ID: 31070023
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A; Høgdall C; Schnack T
Gynecol Oncol; 2022 Jun; 165(3):506-513. PubMed ID: 35346512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
Ding C; Dai DY; Luo ZK; Wang GY; Dong Z; Qin GJ; Du XJ; Ma J
Oral Oncol; 2024 Apr; 151():106725. PubMed ID: 38430711
[TBL] [Abstract][Full Text] [Related]
12. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
[TBL] [Abstract][Full Text] [Related]
13. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH; Kwong DL; Leung TW; Choi CW; O'Sullivan B; Lam KO; Lai V; Khong PL; Chan SK; Ng CY; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; So TH; Luk MY; Lee AW
Int J Cancer; 2019 Apr; 144(7):1713-1722. PubMed ID: 30192385
[TBL] [Abstract][Full Text] [Related]
14. Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients.
Zheng RR; Huang XX; Jin C; Zhuang XX; Ye LC; Zheng FY; Lin F
Clin Chim Acta; 2017 Oct; 473():198-203. PubMed ID: 27836106
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.
Halle MK; Bozickovic O; Forsse D; Wagner-Larsen KS; Gold RM; Lura NG; Woie K; Bertelsen BI; Haldorsen IS; Krakstad C
Gynecol Oncol; 2024 Feb; 181():110-117. PubMed ID: 38150835
[TBL] [Abstract][Full Text] [Related]
16. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
Chen YT; Huang ZP; Zhou ZW; He MM
Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
[TBL] [Abstract][Full Text] [Related]
17. Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.
Guo Q; Lu T; Hui Huang S; O'Sullivan B; Zong J; Xiao Y; Xu W; Chen C; Qiu S; Xu L; Zheng W; Chen Y; Lin S; Pan J
Oral Oncol; 2019 Apr; 91():113-120. PubMed ID: 30926056
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
Raut CP; Nucci MR; Wang Q; Manola J; Bertagnolli MM; Demetri GD; Morgan JA; Muto MG; Fletcher CD; George S
Eur J Cancer; 2009 Nov; 45(16):2818-24. PubMed ID: 19647426
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Husain ZA; Chen T; Corso CD; Wang Z; Park H; Judson B; Yarbrough W; Deshpande H; Mehra S; Kuo P; Decker RH; Burtness BA
JAMA Oncol; 2017 Mar; 3(3):358-365. PubMed ID: 27737449
[TBL] [Abstract][Full Text] [Related]
20. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.
Hui EP; Li WF; Ma BB; Lam WKJ; Chan KCA; Mo F; Ai QYH; King AD; Wong CH; Guo R; Poon DMC; Tong M; Li L; Lau TKH; Wong KCW; Lam DCM; Lo YMD; Ma J; Chan ATC
Ann Oncol; 2020 Jun; 31(6):769-779. PubMed ID: 32217076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]